Pacific Biosciences Of California reported $15.74M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
Bruker USD 416M 36.2M Jun/2026
Danaher USD 3.61B 20M Jun/2026
General Electric Aerospace USD 4.46B 220M Jun/2026
Illumina USD 770M 49M Jun/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Standard Biotools USD 11.31M 74K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 490M 52M Jun/2026